Qiang G. Qu

Guangzhou Road 300
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 190 publications

Response to Letter to the Editor "Methodological Considerations on the Longitudinal Analysis of Polymyxin B‑Induced Kidney Injury" [Response to Letter].

Response to Letter to the Editor "Methodological Considerations on the Longitudinal Analysis of Polymyxin B‑Induced Kidney Injury" [Response to Letter].

Journal: Drug design, development and therapy

Published: July 21, 2026

Pharmacokinetic/pharmacodynamic target attainment of eravacycline in a liver transplant recipient with refractory VRE faecium infection.

Pharmacokinetic/pharmacodynamic target attainment of eravacycline in a liver transplant recipient with refractory VRE faecium infection.

Journal: Antimicrobial agents and chemotherapy

Published: May 28, 2026

Therapeutic Drug Monitoring of Aztreonam-Avibactam in Critically Ill Patients with CRKP Infections and Variable Renal Function: A Case Series.

Therapeutic Drug Monitoring of Aztreonam-Avibactam in Critically Ill Patients with CRKP Infections and Variable Renal Function: A Case Series.

Journal: International journal of antimicrobial agents

Published: May 05, 2026

From Initiation to Recovery: A Longitudinal Analysis of Polymyxin B-Induced Kidney Injury in Clinical Practice.

From Initiation to Recovery: A Longitudinal Analysis of Polymyxin B-Induced Kidney Injury in Clinical Practice.

Journal: Drug design, development and therapy

Published: April 08, 2026

Cerebrospinal fluid and plasma pharmacokinetics of ceftazidime/avibactam in a neurocritical patient with CRKP intracranial infection and augmented renal clearance.

Cerebrospinal fluid and plasma pharmacokinetics of ceftazidime/avibactam in a neurocritical patient with CRKP intracranial infection and augmented renal clearance.

Journal: JAC-antimicrobial resistance

Published: December 04, 2025

Comparative Prognostic Assessment of European Kidney Function Consortium Equations for Mortality Prediction: A Population-Based Cohort Study.

Comparative Prognostic Assessment of European Kidney Function Consortium Equations for Mortality Prediction: A Population-Based Cohort Study.

Journal: Cardiorenal medicine

Published: October 17, 2025

Stepwise De-solvation and Diffusion Kinetics of Hydrated Zn-ion in Hierarchical Porous Carbon Anode for Improved EDLC Behavior.

Stepwise De-solvation and Diffusion Kinetics of Hydrated Zn-ion in Hierarchical Porous Carbon Anode for Improved EDLC Behavior.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 06, 2025

Bibliometric Analysis of White Matter Disease and Novel Drug Therapy.

Bibliometric Analysis of White Matter Disease and Novel Drug Therapy.

Journal: Current neuropharmacology

Published: September 24, 2025

Impact of inflammatory and nutritional parameters on mortality in cardiovascular multimorbidity: a comprehensive prognostic analysis based on two datasets.

Impact of inflammatory and nutritional parameters on mortality in cardiovascular multimorbidity: a comprehensive prognostic analysis based on two datasets.

Journal: Frontiers in nutrition

Published: September 09, 2025

Trends in prevalence of chronic kidney disease and risk management among US adults with diabetes, 2001 to 2020.

Trends in prevalence of chronic kidney disease and risk management among US adults with diabetes, 2001 to 2020.

Journal: Acta diabetologica

Published: September 08, 2025

A disproportionality analysis of adverse events associated with omadacycline based on the FDA adverse event reporting system database.

A disproportionality analysis of adverse events associated with omadacycline based on the FDA adverse event reporting system database.

Journal: The Journal of antimicrobial chemotherapy

Published: July 24, 2025

Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expression.

Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expression.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: May 15, 2025

Showing 1-12 of 190

Last Updated: 09/26/2026